Emerging as a significant development in the struggle against obesity, Retatrutide is attracting considerable buzz. It combines effects of two established GLP-1 receptor agonists, dulaglutide , and an unique glucose-dependent incretin component. Preliminary study data have shown significant weight decrease in people with a high BMI , potentially pr